Biomet M2a Magnum Hip Implant Lawsuits

A growing number of Biomet hip implant lawsuits have been filed over serious injuries allegedly caused by the Biomet M2a Magnum Hip Replacement System. Biomet hip replacement lawsuits allege the metal-on-metal design of the Biomet M2a Magnum hip causes it to flake off tiny metal ions into the tissue surrounding the implant, leading to premature device failure, metallosis and other complications. Many of the individuals who have filed a Biomet hip implant lawsuit have had to undergo painful revision surgery to have their artificial hips removed and replaced. Gilman Law LLP, a leading consumer protection law firm with over 30 years of experience safeguarding the rights of victims, is investigating legal claims on behalf of any Biomet M2a Magnum hip recipient who experienced:

Biomet M2a Magnum

Biomet M2a Magnum

  • Pain and Swelling
  • Difficulty walking
  • Heavy metal poisoning
  • Metallosis
  • Formation of pseudotumors
  • Premature device failure
  • Need for revision surgery

Biomet hip replacement lawsuits are rapidly moving forward in federal court. If you suffered a disabling injury because of the failure of your Biomet M2a Magnum hip implant, we urge you to contact Gilman Law LLP today to learn more about filing a Biomet hip replacement lawsuit.

Biomet Metal-on-Metal Hip Implants

Biomet M2a Magnum hip implants, like most metal-on-metal hip replacements, were approved through a U.S. Food & Drug Administration (FDA) program called 510(k) clearance. Most people would be surprised to learn that medical devices approved through this system are not required to go through human clinical trials. Thanks to a number of high-profile safety controversies, the 510(k) system has come under a great deal of criticism, with many experts charging that the process is responsible for allowing dangerous medical devices – including metal-on-metal hips – to come to market.

The FDA began a safety review of metal-on-metal hips in February 2011, shortly after the all-metal DePuy ASR hip replacement was recalled in August 2010. The FDA has since ordered the makers of metal-on-metal hips, including Biomet, to conduct post-market safety studies of their products to aid in this review. In July 2012, a panel of outside advisers convened by the FDA concluded their risks outweighed their benefits, and stated there were few valid reasons for using the devices. Finally, in January 2013, the FDA advised patients fitted with all-metal hip implants to undergo blood tests to detect elevated metal ion levels, as well as imaging, should they experience symptoms of a failing hip implant. Most significantly, the FDA proposed new regulations that would make metal-on-metal hips like the Biomet M2a Magnum hip implant ineligible for 510(k) clearance.

Legal Help for Victims of Biomet M2a Magnum Hip Replacements

In October 2012, Biomet M2a Magnum hip implant lawsuits were consolidated in a multidistrict litigation in U.S. District Court, Northern District of Indiana. By January 2013, more than 140 Biomet hip lawsuits had been filed in the consolidated proceeding. Victims of failed Biomet hip implants may be entitled to significant compensation, including damages for pain and suffering, permanent disability and emotional distress. If the quality of your life was diminished because of the Biomet M2a Magnum hip replacement, the lawyers at Gilman Law LLP are here to help. For a no-obligation evaluation of your case, please fill out our online free consultation form or call us direct to speak with one of our attorneys at (888) 252-0048.

Awards & Recognition

Gilman Law LLP and its attorneys have been recognized by the leading legal publications and are listed in:


Avvo Rating
Life Member, Multi-Million Dollar Advocates Forum
Life Member, Million Dollar Advocates Forum
Super Lawyers
Lexis Nexis
LawDragon
Association of Trial Lawyers of America
Massachusetts Association of Woman's Lawyers
American Association of Justice: Leaders Forum
American Bar Association and Member of the ABA Antitrust and Litigation Sections and Forum on Franchising and Litigation Section
Public Investors Arbitration Bar Association